💬 Viewpoint: Federal bans on terms related to diversity, equity, and inclusion limit effective patient-clinician communication, impede health care research, and challenge the delivery of patient-centered care.
ja.ma/4juoezG
🚨Just launched: OPTIMISE recommendations to help ensure consent processes in trials are more inclusive of people with communication and/or decision-making needs
⬇️download recommendations
ℹ️links to examples & info
🎦recorded webinar
↔️other resources
🔗https://www.capacityconsentresearch.com/optimise
Shariq et al's scoping review on barriers & facilitators in the recruitment of people with a disability draws on 5 themes
Risk v benefit
Design & management of recruitment protocol
Internal & external validity
Consent & ethics
Systemic factors
#MethodologyMonday
pmc.ncbi.nlm.nih.gov/articles/PMC...
Fantastic to see Prof Frances Shiely, our Director of Education, highlighting the great work of the SENSITISE @sensitise-eu.bsky.social project on Newstalk with Pat Kenny.
Take a listen: www.newstalk.com/podcasts/hig...
📣 Our @streweek.bsky.social is lead author on an editorial in #Trials outlining a new mandate in the journal - mandating the reporting of six key participant characteristics in any protocol/trial report submitted to Trials on or after 1st Jan 2026. 1/2
trialsjournal.biomedcentral.com/articles/10....
What drives willingness to participate in health research?
Led by our #PhD student Zara Kayani, participation and consent to data linkage varies across demographic groups.
Inclusive recruitment strategies are essential to engage underserved communities.
journals.plos.org/plosone/arti...
HRB - Clinical Research Facility - UCC
Key concepts series: Estimands: what they are and why we should use them - Journal of Clinical Epidemiology www.jclinepi.com/article/S089...
SENSITISE (Inclusive clinical trials education)
Aberdeen Centre for Evaluation (formerly HSRU)
Dr Victoria Shepherd
Use of the pragmatic-explanatory continuum indicator summary tool in low- and middle-income country settings: Systematic review - Journal of Clinical Epidemiology www.jclinepi.com/article/S089...
Retrospective use of the PRECIS-2 trial design tool to assess design choices in randomised controlled trials; An empirical review - Journal of Clinical Epidemiology www.jclinepi.com/article/S089...
JAMA
NIHR ARC East Midlands
Journal of Clinical Epidemiology
Journal of Clinical Epidemiology
Journal of Clinical Epidemiology
Background Lower rates of participation in research by ethnic minority groups and socioeconomically deprived populations has led to efforts to develop recruitment strategies which aim to address this ...
In clinical trials, post-randomisation events, such as treatment discontinuation or
the use of rescue medication, can complicate the interpretation of results. An estimand
is a precise description of ...
The pragmatic-explanatory continuum indicator summary (PRECIS) tools were created
to help researchers design better studies. The tools were developed mainly by researchers
from developed Western natio...
Underrepresentation of disabled groups in clinical trials results in an inadequate evidence base for their clinical care, which drives health inequalities. This study aims to review and map the potential barriers and facilitators to the recruitment ...
A new campaign at UCC aims to make health research more inclusive, to include under-served groups...
www.newstalk.com
The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS-2) tool has been widely
used to help investigators design randomised trials, facilitating the task of aligning
design choices with an expl...
